ExodusPoint Capital Management’s Transmedics TMDX Stock Holding History

ExodusPoint Capital Management’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11.5M	Buy	+115,345	New	+$15M	0.09%	201
2025 Q3	–	Sell	-139,407	Closed	-$18.7M	–	2020
2025 Q2	$18.7M	Buy	+139,407	New	+$15.3M	0.16%	123
2024 Q4	–	Sell	-21,405	Closed	-$3.36M	–	2058
2024 Q3	$3.36M	Sell	21,405 -41,285	-66%	-$6.36M	0.02%	554
2024 Q2	$9.44M	Buy	+62,690	New	+$7.52M	0.06%	263
2024 Q1	–	Sell	-8,401	Closed	-$663K	–	1957
2023 Q4	$663K	Buy	8,401 +3,400	+68%	+$205K	﹤0.01%	959
2023 Q3	$274K	Buy	+5,001	New	+$360K	﹤0.01%	1441

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ExodusPoint Capital Management's TMDX Position: Q1 2026 in Review

ExodusPoint Capital Management opened a new position in Transmedics (TMDX) in Q1 2026: 115,345 shares worth $11.5M. The stake represents 0.09% of the portfolio and ranks #201 among its holdings. This is a return to the name: ExodusPoint Capital Management previously reported a position in TMDX as recently as Q2 2025.

ExodusPoint Capital Management first reported a position in TMDX in Q3 2023 and has held it in 6 quarters since. The position peaked at $18.7M in Q2 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

ExodusPoint Capital Management held 115,345 shares of Transmedics worth $11.5M as of Q1 2026.
Transmedics was a new ExodusPoint Capital Management position in Q1 2026.
Transmedics made up 0.09% of ExodusPoint Capital Management's portfolio in Q1 2026, its #201 holding.
ExodusPoint Capital Management first reported a position in Transmedics in Q3 2023 and has held it in 6 quarters since.
ExodusPoint Capital Management's Transmedics position peaked at $18.7M in Q2 2025.
414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.